VIPR2 (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "VIPR2" in Serbian language version.

Last modified: 00:50:24, 8 June 2026 (UTC)

Ref.Un. Ref.Website

Global rank Serbian rank

1413nih.gov

5^th place

7^th place

1010doi.org

2^nd place

5^th place

55archive.org

6^th place

8^th place

11web.archive.org

1^st place

2^nd place

11iuphar-db.org

low place

archive.org (Global: 6^th place; Serbian: 8^th place)

Reubi JC, Laderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA (2000). „Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.”. Cancer Res. 60 (11): 3105—3112. PMID 10850463.
Harmar AJ, Marston HM, Shen S, Spratt C, West KM, Sheward WJ, Morrison CF, Dorin JR, Piggins HD, Reubi JC, Kelly JS, Maywood ES, Hastings MH (2002). „The VPAC2 receptor is essential for circadian function in the mouse suprachiasmatic nuclei.”. Cell. 109 (4): 497—508. PMID 12086606. doi:10.1016/S0092-8674(02)00736-5.
Hughes AT, Fahey B, Cutler DJ, Coogan AN, Piggins HD (2004). „Aberrant gating of photic input to the suprachiasmatic circadian pacemaker of mice lacking the VPAC2 receptor”. J. Neurosci.. 24 (14): 3522—6. PMID 15071099. doi:10.1523/JNEUROSCI.5345-03.2004.
Kellogg DL, Zhao JL, Wu Y, Johnson JM (2010). „VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans”. J. Appl. Physiol.. 109 (1): 95—100. PMC 2904198 . PMID 20395540. doi:10.1152/japplphysiol.01187.2009.
Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J, Zhang N, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Kendler KS, Freedman R, Dudbridge F, Pe'er I, Hakonarson H, Bergen SE, Fanous AH, Holmans PA, Gejman PV (2011). „Copy Number Variants in Schizophrenia: Confirmation of Five Previous Findings and New Evidence for 3q29 Microdeletions and VIPR2 Duplications”. Am J Psychiatry. 168 (3): 302—316. PMID 21285140. doi:10.1176/appi.ajp.2010.10060876.

doi.org (Global: 2^nd place; Serbian: 5^th place)

Reubi JC (2000). „In vitro evaluation of VIP/PACAP receptors in healthy and diseased human tissues. Clinical implications.”. Ann N Y Acad Sci. 921 (1): 1—25. PMID 11193811. doi:10.1111/j.1749-6632.2000.tb06946.x.
Basille M, Cartier D, Vaudry D, Lihrmann I, Fournier A, Freger P, Gallo-Payet N, Vaudry H, Gonzalez B (2006). „Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development”. J. Comp. Neurol.. 496 (4): 468—78. PMID 16572459. doi:10.1002/cne.20934.
Juarranz Y, Gutiérrez-Cañas I, Santiago B, Carrión M, Pablos JL, Gomariz RP (2008). „Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts”. Arthritis Rheum.. 58 (4): 1086—95. PMID 18383383. doi:10.1002/art.23403.
Harmar AJ, Marston HM, Shen S, Spratt C, West KM, Sheward WJ, Morrison CF, Dorin JR, Piggins HD, Reubi JC, Kelly JS, Maywood ES, Hastings MH (2002). „The VPAC2 receptor is essential for circadian function in the mouse suprachiasmatic nuclei.”. Cell. 109 (4): 497—508. PMID 12086606. doi:10.1016/S0092-8674(02)00736-5.
Cutler DJ, Haraura M, Reed HE, Shen S, Sheward WJ, Morrison CF, Marston HM, Harmar AJ, Piggins HD (2003). „The mouse VPAC2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitro”. Eur. J. Neurosci.. 17 (2): 197—204. PMID 12542655. doi:10.1046/j.1460-9568.2003.02425.x.
Hughes AT, Fahey B, Cutler DJ, Coogan AN, Piggins HD (2004). „Aberrant gating of photic input to the suprachiasmatic circadian pacemaker of mice lacking the VPAC2 receptor”. J. Neurosci.. 24 (14): 3522—6. PMID 15071099. doi:10.1523/JNEUROSCI.5345-03.2004.
Asnicar MA, Köster A, Heiman ML, Tinsley F, Smith DP, Galbreath E, Fox N, Ma YL, Blum WF, Hsiung HM (2002). „Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate”. Endocrinology. 143 (10): 3994—4006. PMID 12239111. doi:10.1210/en.2002-220354.
Kellogg DL, Zhao JL, Wu Y, Johnson JM (2010). „VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans”. J. Appl. Physiol.. 109 (1): 95—100. PMC 2904198 . PMID 20395540. doi:10.1152/japplphysiol.01187.2009.
Miller AL, Verma D, Grinninger C, Huang MC, Goetzl EJ (2006). „Functional splice variants of the type II G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide in mouse and human lymphocytes”. Ann. N. Y. Acad. Sci.. 1070 (1): 422—6. PMC 1557659 . PMID 16888203. doi:10.1196/annals.1317.055.
Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J, Zhang N, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Kendler KS, Freedman R, Dudbridge F, Pe'er I, Hakonarson H, Bergen SE, Fanous AH, Holmans PA, Gejman PV (2011). „Copy Number Variants in Schizophrenia: Confirmation of Five Previous Findings and New Evidence for 3q29 Microdeletions and VIPR2 Duplications”. Am J Psychiatry. 168 (3): 302—316. PMID 21285140. doi:10.1176/appi.ajp.2010.10060876.

iuphar-db.org (Global: low place; Serbian: low place)

„Архивирана копија”. Архивирано из оригинала 03. 03. 2016. г. Приступљено 04. 08. 2012.

nih.gov (Global: 5^th place; Serbian: 7^th place)

ncbi.nlm.nih.gov

„Entrez Gene: VIPR2 vasoactive intestinal peptide receptor 2”.
Reubi JC (2000). „In vitro evaluation of VIP/PACAP receptors in healthy and diseased human tissues. Clinical implications.”. Ann N Y Acad Sci. 921 (1): 1—25. PMID 11193811. doi:10.1111/j.1749-6632.2000.tb06946.x.
Reubi JC, Laderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA (2000). „Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.”. Cancer Res. 60 (11): 3105—3112. PMID 10850463.
Basille M, Cartier D, Vaudry D, Lihrmann I, Fournier A, Freger P, Gallo-Payet N, Vaudry H, Gonzalez B (2006). „Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development”. J. Comp. Neurol.. 496 (4): 468—78. PMID 16572459. doi:10.1002/cne.20934.
Juarranz Y, Gutiérrez-Cañas I, Santiago B, Carrión M, Pablos JL, Gomariz RP (2008). „Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts”. Arthritis Rheum.. 58 (4): 1086—95. PMID 18383383. doi:10.1002/art.23403.
Harmar AJ, Marston HM, Shen S, Spratt C, West KM, Sheward WJ, Morrison CF, Dorin JR, Piggins HD, Reubi JC, Kelly JS, Maywood ES, Hastings MH (2002). „The VPAC2 receptor is essential for circadian function in the mouse suprachiasmatic nuclei.”. Cell. 109 (4): 497—508. PMID 12086606. doi:10.1016/S0092-8674(02)00736-5.
Cutler DJ, Haraura M, Reed HE, Shen S, Sheward WJ, Morrison CF, Marston HM, Harmar AJ, Piggins HD (2003). „The mouse VPAC2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitro”. Eur. J. Neurosci.. 17 (2): 197—204. PMID 12542655. doi:10.1046/j.1460-9568.2003.02425.x.
Hughes AT, Fahey B, Cutler DJ, Coogan AN, Piggins HD (2004). „Aberrant gating of photic input to the suprachiasmatic circadian pacemaker of mice lacking the VPAC2 receptor”. J. Neurosci.. 24 (14): 3522—6. PMID 15071099. doi:10.1523/JNEUROSCI.5345-03.2004.
Asnicar MA, Köster A, Heiman ML, Tinsley F, Smith DP, Galbreath E, Fox N, Ma YL, Blum WF, Hsiung HM (2002). „Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate”. Endocrinology. 143 (10): 3994—4006. PMID 12239111. doi:10.1210/en.2002-220354.
Kellogg DL, Zhao JL, Wu Y, Johnson JM (2010). „VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans”. J. Appl. Physiol.. 109 (1): 95—100. PMC 2904198 . PMID 20395540. doi:10.1152/japplphysiol.01187.2009.
Miller AL, Verma D, Grinninger C, Huang MC, Goetzl EJ (2006). „Functional splice variants of the type II G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide in mouse and human lymphocytes”. Ann. N. Y. Acad. Sci.. 1070 (1): 422—6. PMC 1557659 . PMID 16888203. doi:10.1196/annals.1317.055.
Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J, Zhang N, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Kendler KS, Freedman R, Dudbridge F, Pe'er I, Hakonarson H, Bergen SE, Fanous AH, Holmans PA, Gejman PV (2011). „Copy Number Variants in Schizophrenia: Confirmation of Five Previous Findings and New Evidence for 3q29 Microdeletions and VIPR2 Duplications”. Am J Psychiatry. 168 (3): 302—316. PMID 21285140. doi:10.1176/appi.ajp.2010.10060876.
Zhang ZH, Wu SD, Gao H, Shi G, Jin JZ, Kong J, Tian Z, Su Y (2006). „Expression of pituitary adenylate cyclase-activating polypeptide 1 and 2 receptor mRNA in gallbladder tissue of patients with gallstone or gallbladder polyps”. World J. Gastroenterol.. 12 (9): 1468—71. PMID 16552823.

web.archive.org (Global: 1^st place; Serbian: 2^nd place)

„Архивирана копија”. Архивирано из оригинала 03. 03. 2016. г. Приступљено 04. 08. 2012.

VIPR2 (Serbian Wikipedia)

archive.org (Global: 6th place; Serbian: 8th place)

doi.org (Global: 2nd place; Serbian: 5th place)